Radiopharm Theranostics Limited (ASX:RAD)
Australia · Delayed Price · Currency is AUD 0.0040
0.00 (0.00%)
Nov 11, 2026, 1:12 PM AEDT
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of 17.35 million as of November 10, 2026. It is the 40,288th most valuable company in the world and the 1,104th biggest in Australia. Its market cap has decreased by 72.87% in one year.
Market Cap
17.35M
Enterprise Value
10.85M
Revenue
12.87M
Global Rank
Country Rank
#1,104 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from 101.33M to 17.35M, a decrease of -82.88%. That is a compound annual growth rate of -29.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 17.35M | -80.42% |
| Dec 31, 2025 | 88.61M | 68.31% |
| Dec 31, 2024 | 52.65M | 91.43% |
| Dec 29, 2023 | 27.50M | -20.28% |
| Dec 30, 2022 | 34.50M | -65.53% |
| Dec 31, 2021 | 100.07M | -1.25% |
| Nov 25, 2021 | 101.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neurotech International | 25.86M |
| Algorae Pharmaceuticals | 20.28M |
| Imugene | 17.63M |
| Miro Sciences | 17.15M |
| Proteomics International Laboratories | 16.04M |
| Ceryvyn Therapeutics | 13.68M |
| EZZ Life Science Holdings | 13.65M |
| Argenica Therapeutics | 13.49M |